Cell and Gene Therapy Platforms are integrated systems encompassing the technologies, processes, and infrastructure required to develop, manufacture, and deliver therapeutic interventions that involve the use of living cells or genetic material. These software platforms include data management systems to handle extensive research and clinical data, regulatory compliance tools to ensure adherence to strict standards, Supply Chain Management which includes tracking systems that monitor the location and status of products throughout, from production to delivery at clinical sites. This capability is vital for meeting the unique challenges of cell and gene therapies, which often require precise temperature controls and timely delivery. Some vendors also refer to these as Advanced Therapy Manufacturers or advanced therapy medicinal products (ATMPs). CGT platforms are used by biotech and pharmaceutical companies, research institutions, clinical facilities, Contract Research Organizations (CROs), and manufacturing organizations to develop, test, and produce advanced therapies. Regulatory agencies also utilize these platforms to evaluate and approve new treatments.